发明授权
US06207170B1 Patient-specific white blood cell malignancy vaccine from membrane-proteoliposomes
失效
来自膜蛋白脂质体的患者特异性白细胞恶性肿瘤疫苗
- 专利标题： Patient-specific white blood cell malignancy vaccine from membrane-proteoliposomes
- 专利标题（中）： 来自膜蛋白脂质体的患者特异性白细胞恶性肿瘤疫苗
-
申请号： US09231650申请日： 1999-01-15
-
公开(公告)号： US06207170B1公开(公告)日： 2001-03-27
- 发明人: Mircea C. Popescu , Lawrence Boni , Richard J. Robb , Michael M. Batenjany
- 申请人： Mircea C. Popescu , Lawrence Boni , Richard J. Robb , Michael M. Batenjany
- 主分类号： A61K3900
- IPC分类号： A61K3900
摘要：
Membrane-proteoliposome structures (MPs) are useful in preparing patient-specific vaccines against specific white blood cell (WBC) malignancies. The inventive MPs typically contain a membrane component derived from a specific WBC. Other useful components include immunostimulators and exogenous lipids. The resulting vaccines are both patient- and malignancy-specific.
信息查询
